Antonio Cano - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Antonio Cano - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2002	13
2003	10
2004	5
2005	7
2006	5
2007	4
2008	7
2009	6
2010	9
2011	6
2012	11
2013	10
2014	9
2015	18
2016	11
2017	9
2018	22
2019	14
2020	26
2021	23
2022	16
2023	17
2024	4

226 results

Page of 23

Results by year

Page 1

Common Methods of Extraction and Determination of Phytomelatonin in Plants.

Cano A, Hernández-Ruiz J, Arnao MB. Cano A, et al. Methods Mol Biol. 2024;2798:161-181. doi: 10.1007/978-1-0716-3826-2_11. Methods Mol Biol. 2024. PMID: 38587742 Review.

Association between anxiety and frailty in postmenopausal women.

García-Vigara A, Fernandez-Garrido J, Chedraui P, Monllor-Tormos A, García-Pérez MÁ, Tarín JJ, Artero A, Cano A. García-Vigara A, et al. Among authors: cano a. Gynecol Endocrinol. 2024 Mar 9;40(1):2329714. doi: 10.1080/09513590.2024.2329714. Epub 2024 Mar 18. Gynecol Endocrinol. 2024. PMID: 38499020 Free article.

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.

Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM; HMT Eligibility Criteria Group. Coronado PJ, et al. Menopause. 2024 Mar 1;31(3):234-242. doi: 10.1097/GME.0000000000002317. Menopause. 2024. PMID: 38385734

Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials.

Cano A, Nappi RE, Santoro N, Stute P, Blogg M, English ML, Morga A, Scrine L, Siddiqui E, Ottery FD. Cano A, et al. BJOG. 2024 Feb 6. doi: 10.1111/1471-0528.17773. Online ahead of print. BJOG. 2024. PMID: 38320967 Free article.

Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer.

Ortiz E, Peña CJ, Hidalgo JJ, Monllor-Tormos A, Zolfaroli I, Vila MJ, Sánchez-Serrano M, Pellicer A, Cano A. Ortiz E, et al. Among authors: cano a. J Assist Reprod Genet. 2023 Dec;40(12):2827-2834. doi: 10.1007/s10815-023-02949-y. Epub 2023 Sep 27. J Assist Reprod Genet. 2023. PMID: 37755614 Free PMC article.

Sequential management of postmenopausal health and osteoporosis: An update.

Calaf-Alsina J, Cano A, Guañabens N, Palacios S, Cancelo MJ, Castelo-Branco C, Larrainzar-Garijo R, Neyro JL, Nogues X, Diez-Perez A. Calaf-Alsina J, et al. Among authors: cano a. Maturitas. 2023 Nov;177:107846. doi: 10.1016/j.maturitas.2023.107846. Epub 2023 Sep 13. Maturitas. 2023. PMID: 37738717 Free article. Review.

Mediterranean diet for cancer prevention and survivorship.

Monllor-Tormos A, García-Vigara A, Morgan O, García-Pérez MÁ, Mendoza N, Tarín JJ, Cano A. Monllor-Tormos A, et al. Among authors: cano a. Maturitas. 2023 Dec;178:107841. doi: 10.1016/j.maturitas.2023.107841. Epub 2023 Aug 24. Maturitas. 2023. PMID: 37660598 Free article. Review.

Both reduced ovarian reserve and severe semen alterations are overrepresented in couples seeking assisted reproductive technology treatment for the first time: a cross-sectional study.

Tarín JJ, Pascual E, García-Pérez MA, Monllor-Tormos A, Cano A. Tarín JJ, et al. Among authors: cano a. Reprod Health. 2023 Aug 16;20(1):117. doi: 10.1186/s12978-023-01666-0. Reprod Health. 2023. PMID: 37582738 Free PMC article.

Pharmacological interactions and menopausal hormone therapy: a review.

Fasero M, Quereda F, Andraca L, Coronado PJ; HT Eligibility Criteria Group. Fasero M, et al. Menopause. 2023 Aug 1;30(8):873-880. doi: 10.1097/GME.0000000000002219. Epub 2023 Jul 11. Menopause. 2023. PMID: 37449718

Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspective.

Rozenberg S, Panay N, Gambacciani M, Cano A, Gray S, Schaudig K. Rozenberg S, et al. Among authors: cano a. Expert Rev Clin Pharmacol. 2023 Jan-Jun;16(6):507-517. doi: 10.1080/17512433.2023.2219056. Epub 2023 Jun 5. Expert Rev Clin Pharmacol. 2023. PMID: 37278023

226 results

Page of 23

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

226 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Results by year